HEADER TRANSFERASE 29-JAN-20 6VNJ TITLE JAK2 JH1 IN COMPLEX WITH PN4-014 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: B, A; COMPND 4 SYNONYM: JANUS KINASE 2,JAK-2; COMPND 5 EC: 2.7.10.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: EXPI293F; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PCDNA 3.3 KEYWDS JANUS ASSOCIATED KINASE, JAK2, KINASE DOMAIN, JH1, KINASE, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.R.DAVIS,E.SCHONBRUNN REVDAT 5 15-NOV-23 6VNJ 1 REMARK REVDAT 4 11-OCT-23 6VNJ 1 REMARK REVDAT 3 10-MAR-21 6VNJ 1 JRNL REVDAT 2 24-FEB-21 6VNJ 1 JRNL REVDAT 1 17-FEB-21 6VNJ 0 JRNL AUTH R.R.DAVIS,B.LI,S.Y.YUN,A.CHAN,P.NAREDDY,S.GUNAWAN,M.AYAZ, JRNL AUTH 2 H.R.LAWRENCE,G.W.REUTHER,N.J.LAWRENCE,E.SCHONBRUNN JRNL TITL STRUCTURAL INSIGHTS INTO JAK2 INHIBITION BY RUXOLITINIB, JRNL TITL 2 FEDRATINIB, AND DERIVATIVES THEREOF. JRNL REF J.MED.CHEM. V. 64 2228 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 33570945 JRNL DOI 10.1021/ACS.JMEDCHEM.0C01952 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14-3260_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.90 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 130820 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.160 REMARK 3 FREE R VALUE TEST SET COUNT : 2822 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.9000 - 5.1548 0.98 6468 143 0.1502 0.1795 REMARK 3 2 5.1548 - 4.0925 0.98 6500 137 0.1375 0.1479 REMARK 3 3 4.0925 - 3.5754 0.97 6416 141 0.1452 0.1552 REMARK 3 4 3.5754 - 3.2486 0.96 6401 138 0.1675 0.1850 REMARK 3 5 3.2486 - 3.0158 0.95 6311 144 0.1834 0.2313 REMARK 3 6 3.0158 - 2.8381 0.97 6465 142 0.1862 0.2211 REMARK 3 7 2.8381 - 2.6960 0.98 6471 152 0.1931 0.2489 REMARK 3 8 2.6960 - 2.5786 0.98 6524 138 0.1994 0.2355 REMARK 3 9 2.5786 - 2.4794 0.98 6464 149 0.2045 0.2230 REMARK 3 10 2.4794 - 2.3938 0.96 6399 141 0.2209 0.2506 REMARK 3 11 2.3938 - 2.3190 0.97 6421 140 0.2319 0.3106 REMARK 3 12 2.3190 - 2.2527 0.97 6448 145 0.2422 0.2854 REMARK 3 13 2.2527 - 2.1934 0.95 6258 142 0.2556 0.2708 REMARK 3 14 2.1934 - 2.1399 0.96 6298 137 0.2701 0.2909 REMARK 3 15 2.1399 - 2.0912 0.97 6450 145 0.2845 0.2898 REMARK 3 16 2.0912 - 2.0467 0.97 6428 146 0.2960 0.3396 REMARK 3 17 2.0467 - 2.0058 0.97 6385 130 0.3180 0.3663 REMARK 3 18 2.0058 - 1.9679 0.97 6466 140 0.3425 0.3369 REMARK 3 19 1.9679 - 1.9328 0.96 6333 133 0.3701 0.3749 REMARK 3 20 1.9328 - 1.9000 0.92 6092 139 0.4036 0.4473 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.950 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 38.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: (CHAIN A AND RESID 842 THROUGH 1131) REMARK 3 SELECTION : CHAIN B REMARK 3 ATOM PAIRS NUMBER : 2840 REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6VNJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JAN-20. REMARK 100 THE DEPOSITION ID IS D_1000246386. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-OCT-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0332 REMARK 200 MONOCHROMATOR : ROSENBAUM-ROCK DOUBLE-CRYSTAL REMARK 200 SI(220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 130820 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 43.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2XA4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS PH 5.5, 0.2 M NACL, 25% REMARK 280 PEG 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.28850 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 17.64425 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 52.93275 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS B 825 REMARK 465 HIS B 826 REMARK 465 HIS B 827 REMARK 465 HIS B 828 REMARK 465 HIS B 829 REMARK 465 HIS B 830 REMARK 465 HIS B 831 REMARK 465 HIS B 832 REMARK 465 GLU B 833 REMARK 465 ASN B 834 REMARK 465 LEU B 835 REMARK 465 TYR B 836 REMARK 465 PHE B 837 REMARK 465 GLN B 838 REMARK 465 GLY B 839 REMARK 465 ASP B 840 REMARK 465 PRO B 841 REMARK 465 GLY B 1132 REMARK 465 HIS A 825 REMARK 465 HIS A 826 REMARK 465 HIS A 827 REMARK 465 HIS A 828 REMARK 465 HIS A 829 REMARK 465 HIS A 830 REMARK 465 HIS A 831 REMARK 465 HIS A 832 REMARK 465 GLU A 833 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 1390 O HOH B 1408 1.80 REMARK 500 O HOH A 1422 O HOH A 1432 1.82 REMARK 500 O HOH B 1309 O HOH B 1386 1.86 REMARK 500 OH TYR B 1021 O HOH B 1301 1.92 REMARK 500 OD2 ASP A 908 O HOH A 1301 1.97 REMARK 500 O ASP A 840 O HOH A 1302 2.00 REMARK 500 O HOH A 1392 O HOH A 1405 2.05 REMARK 500 OE2 GLU B 877 O HOH B 1302 2.07 REMARK 500 O GLU A 1052 O HOH A 1303 2.09 REMARK 500 NZ LYS B 850 O HOH B 1303 2.18 REMARK 500 O HOH B 1369 O HOH B 1417 2.18 REMARK 500 OE2 GLU B 1104 O HOH B 1304 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NZ LYS B 883 O3P PTR B 1007 2654 1.30 REMARK 500 O HOH B 1375 O HOH A 1369 3554 1.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN B 843 69.57 -107.71 REMARK 500 ARG B 975 -2.12 70.61 REMARK 500 ASP B 976 40.50 -143.34 REMARK 500 TRP B1106 40.91 -92.75 REMARK 500 LEU A 835 -95.19 66.41 REMARK 500 PRO A 841 130.73 -25.18 REMARK 500 THR A 842 6.77 87.56 REMARK 500 ARG A 975 -3.37 72.13 REMARK 500 ASP A 976 44.19 -144.72 REMARK 500 TRP A1106 38.44 -94.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN B 859 PHE B 860 -117.12 REMARK 500 ASP A 840 PRO A 841 -127.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue R5S B 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue R5S A 1201 DBREF 6VNJ B 840 1132 UNP O60674 JAK2_HUMAN 840 1132 DBREF 6VNJ A 840 1132 UNP O60674 JAK2_HUMAN 840 1132 SEQADV 6VNJ HIS B 825 UNP O60674 EXPRESSION TAG SEQADV 6VNJ HIS B 826 UNP O60674 EXPRESSION TAG SEQADV 6VNJ HIS B 827 UNP O60674 EXPRESSION TAG SEQADV 6VNJ HIS B 828 UNP O60674 EXPRESSION TAG SEQADV 6VNJ HIS B 829 UNP O60674 EXPRESSION TAG SEQADV 6VNJ HIS B 830 UNP O60674 EXPRESSION TAG SEQADV 6VNJ HIS B 831 UNP O60674 EXPRESSION TAG SEQADV 6VNJ HIS B 832 UNP O60674 EXPRESSION TAG SEQADV 6VNJ GLU B 833 UNP O60674 EXPRESSION TAG SEQADV 6VNJ ASN B 834 UNP O60674 EXPRESSION TAG SEQADV 6VNJ LEU B 835 UNP O60674 EXPRESSION TAG SEQADV 6VNJ TYR B 836 UNP O60674 EXPRESSION TAG SEQADV 6VNJ PHE B 837 UNP O60674 EXPRESSION TAG SEQADV 6VNJ GLN B 838 UNP O60674 EXPRESSION TAG SEQADV 6VNJ GLY B 839 UNP O60674 EXPRESSION TAG SEQADV 6VNJ HIS A 825 UNP O60674 EXPRESSION TAG SEQADV 6VNJ HIS A 826 UNP O60674 EXPRESSION TAG SEQADV 6VNJ HIS A 827 UNP O60674 EXPRESSION TAG SEQADV 6VNJ HIS A 828 UNP O60674 EXPRESSION TAG SEQADV 6VNJ HIS A 829 UNP O60674 EXPRESSION TAG SEQADV 6VNJ HIS A 830 UNP O60674 EXPRESSION TAG SEQADV 6VNJ HIS A 831 UNP O60674 EXPRESSION TAG SEQADV 6VNJ HIS A 832 UNP O60674 EXPRESSION TAG SEQADV 6VNJ GLU A 833 UNP O60674 EXPRESSION TAG SEQADV 6VNJ ASN A 834 UNP O60674 EXPRESSION TAG SEQADV 6VNJ LEU A 835 UNP O60674 EXPRESSION TAG SEQADV 6VNJ TYR A 836 UNP O60674 EXPRESSION TAG SEQADV 6VNJ PHE A 837 UNP O60674 EXPRESSION TAG SEQADV 6VNJ GLN A 838 UNP O60674 EXPRESSION TAG SEQADV 6VNJ GLY A 839 UNP O60674 EXPRESSION TAG SEQRES 1 B 308 HIS HIS HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE SEQRES 2 B 308 GLN GLY ASP PRO THR GLN PHE GLU GLU ARG HIS LEU LYS SEQRES 3 B 308 PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE GLY SER VAL SEQRES 4 B 308 GLU MET CYS ARG TYR ASP PRO LEU GLN ASP ASN THR GLY SEQRES 5 B 308 GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SER THR GLU SEQRES 6 B 308 GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE GLU ILE LEU SEQRES 7 B 308 LYS SER LEU GLN HIS ASP ASN ILE VAL LYS TYR LYS GLY SEQRES 8 B 308 VAL CYS TYR SER ALA GLY ARG ARG ASN LEU LYS LEU ILE SEQRES 9 B 308 MET GLU TYR LEU PRO TYR GLY SER LEU ARG ASP TYR LEU SEQRES 10 B 308 GLN LYS HIS LYS GLU ARG ILE ASP HIS ILE LYS LEU LEU SEQRES 11 B 308 GLN TYR THR SER GLN ILE CYS LYS GLY MET GLU TYR LEU SEQRES 12 B 308 GLY THR LYS ARG TYR ILE HIS ARG ASP LEU ALA THR ARG SEQRES 13 B 308 ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL LYS ILE GLY SEQRES 14 B 308 ASP PHE GLY LEU THR LYS VAL LEU PRO GLN ASP LYS GLU SEQRES 15 B 308 PTR TYR LYS VAL LYS GLU PRO GLY GLU SER PRO ILE PHE SEQRES 16 B 308 TRP TYR ALA PRO GLU SER LEU THR GLU SER LYS PHE SER SEQRES 17 B 308 VAL ALA SER ASP VAL TRP SER PHE GLY VAL VAL LEU TYR SEQRES 18 B 308 GLU LEU PHE THR TYR ILE GLU LYS SER LYS SER PRO PRO SEQRES 19 B 308 ALA GLU PHE MET ARG MET ILE GLY ASN ASP LYS GLN GLY SEQRES 20 B 308 GLN MET ILE VAL PHE HIS LEU ILE GLU LEU LEU LYS ASN SEQRES 21 B 308 ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS PRO ASP GLU SEQRES 22 B 308 ILE TYR MET ILE MET THR GLU CYS TRP ASN ASN ASN VAL SEQRES 23 B 308 ASN GLN ARG PRO SER PHE ARG ASP LEU ALA LEU ARG VAL SEQRES 24 B 308 ASP GLN ILE ARG ASP ASN MET ALA GLY SEQRES 1 A 308 HIS HIS HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE SEQRES 2 A 308 GLN GLY ASP PRO THR GLN PHE GLU GLU ARG HIS LEU LYS SEQRES 3 A 308 PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE GLY SER VAL SEQRES 4 A 308 GLU MET CYS ARG TYR ASP PRO LEU GLN ASP ASN THR GLY SEQRES 5 A 308 GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SER THR GLU SEQRES 6 A 308 GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE GLU ILE LEU SEQRES 7 A 308 LYS SER LEU GLN HIS ASP ASN ILE VAL LYS TYR LYS GLY SEQRES 8 A 308 VAL CYS TYR SER ALA GLY ARG ARG ASN LEU LYS LEU ILE SEQRES 9 A 308 MET GLU TYR LEU PRO TYR GLY SER LEU ARG ASP TYR LEU SEQRES 10 A 308 GLN LYS HIS LYS GLU ARG ILE ASP HIS ILE LYS LEU LEU SEQRES 11 A 308 GLN TYR THR SER GLN ILE CYS LYS GLY MET GLU TYR LEU SEQRES 12 A 308 GLY THR LYS ARG TYR ILE HIS ARG ASP LEU ALA THR ARG SEQRES 13 A 308 ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL LYS ILE GLY SEQRES 14 A 308 ASP PHE GLY LEU THR LYS VAL LEU PRO GLN ASP LYS GLU SEQRES 15 A 308 PTR TYR LYS VAL LYS GLU PRO GLY GLU SER PRO ILE PHE SEQRES 16 A 308 TRP TYR ALA PRO GLU SER LEU THR GLU SER LYS PHE SER SEQRES 17 A 308 VAL ALA SER ASP VAL TRP SER PHE GLY VAL VAL LEU TYR SEQRES 18 A 308 GLU LEU PHE THR TYR ILE GLU LYS SER LYS SER PRO PRO SEQRES 19 A 308 ALA GLU PHE MET ARG MET ILE GLY ASN ASP LYS GLN GLY SEQRES 20 A 308 GLN MET ILE VAL PHE HIS LEU ILE GLU LEU LEU LYS ASN SEQRES 21 A 308 ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS PRO ASP GLU SEQRES 22 A 308 ILE TYR MET ILE MET THR GLU CYS TRP ASN ASN ASN VAL SEQRES 23 A 308 ASN GLN ARG PRO SER PHE ARG ASP LEU ALA LEU ARG VAL SEQRES 24 A 308 ASP GLN ILE ARG ASP ASN MET ALA GLY MODRES 6VNJ PTR B 1007 TYR MODIFIED RESIDUE MODRES 6VNJ PTR A 1007 TYR MODIFIED RESIDUE HET PTR B1007 16 HET PTR A1007 16 HET R5S B1201 31 HET R5S A1201 31 HETNAM PTR O-PHOSPHOTYROSINE HETNAM R5S 3-[4-(2-{[4-(PIPERIDIN-4-YL)PHENYL]AMINO}-6,7-DIHYDRO- HETNAM 2 R5S 5H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1- HETNAM 3 R5S YL]PROPANENITRILE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 3 R5S 2(C23 H26 N8) FORMUL 5 HOH *264(H2 O) HELIX 1 AA1 GLU B 845 ARG B 847 5 3 HELIX 2 AA2 THR B 888 SER B 904 1 17 HELIX 3 AA3 SER B 936 HIS B 944 1 9 HELIX 4 AA4 LYS B 945 ILE B 948 5 4 HELIX 5 AA5 ASP B 949 LYS B 970 1 22 HELIX 6 AA6 ALA B 978 ARG B 980 5 3 HELIX 7 AA7 PRO B 1017 TYR B 1021 5 5 HELIX 8 AA8 ALA B 1022 SER B 1029 1 8 HELIX 9 AA9 VAL B 1033 TYR B 1050 1 18 HELIX 10 AB1 GLU B 1052 LYS B 1055 5 4 HELIX 11 AB2 SER B 1056 GLY B 1066 1 11 HELIX 12 AB3 GLY B 1071 ASN B 1084 1 14 HELIX 13 AB4 PRO B 1095 TRP B 1106 1 12 HELIX 14 AB5 ASN B 1109 ARG B 1113 5 5 HELIX 15 AB6 SER B 1115 ALA B 1131 1 17 HELIX 16 AB7 GLU A 845 ARG A 847 5 3 HELIX 17 AB8 THR A 888 SER A 904 1 17 HELIX 18 AB9 SER A 936 HIS A 944 1 9 HELIX 19 AC1 ASP A 949 LYS A 970 1 22 HELIX 20 AC2 ALA A 978 ARG A 980 5 3 HELIX 21 AC3 PRO A 1017 TYR A 1021 5 5 HELIX 22 AC4 ALA A 1022 SER A 1029 1 8 HELIX 23 AC5 SER A 1032 THR A 1049 1 18 HELIX 24 AC6 GLU A 1052 LYS A 1055 5 4 HELIX 25 AC7 SER A 1056 GLY A 1066 1 11 HELIX 26 AC8 GLY A 1071 ASN A 1084 1 14 HELIX 27 AC9 PRO A 1095 TRP A 1106 1 12 HELIX 28 AD1 ASN A 1109 ARG A 1113 5 5 HELIX 29 AD2 SER A 1115 ALA A 1131 1 17 SHEET 1 AA1 5 LEU B 849 GLY B 858 0 SHEET 2 AA1 5 GLY B 861 TYR B 868 -1 O MET B 865 N GLN B 853 SHEET 3 AA1 5 GLU B 877 LEU B 884 -1 O VAL B 879 N CYS B 866 SHEET 4 AA1 5 LYS B 926 GLU B 930 -1 O MET B 929 N ALA B 880 SHEET 5 AA1 5 TYR B 913 CYS B 917 -1 N GLY B 915 O ILE B 928 SHEET 1 AA2 2 TYR B 972 ILE B 973 0 SHEET 2 AA2 2 LYS B 999 VAL B1000 -1 O LYS B 999 N ILE B 973 SHEET 1 AA3 2 ILE B 982 ASN B 986 0 SHEET 2 AA3 2 ARG B 989 ILE B 992 -1 O LYS B 991 N LEU B 983 SHEET 1 AA4 2 PTR B1007 LYS B1009 0 SHEET 2 AA4 2 LYS B1030 SER B1032 -1 O PHE B1031 N TYR B1008 SHEET 1 AA5 5 LEU A 849 LYS A 857 0 SHEET 2 AA5 5 GLY A 861 TYR A 868 -1 O MET A 865 N GLN A 853 SHEET 3 AA5 5 GLU A 877 LEU A 884 -1 O GLU A 877 N TYR A 868 SHEET 4 AA5 5 ARG A 923 GLU A 930 -1 O MET A 929 N ALA A 880 SHEET 5 AA5 5 TYR A 913 SER A 919 -1 N SER A 919 O ARG A 923 SHEET 1 AA6 2 TYR A 972 ILE A 973 0 SHEET 2 AA6 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 AA7 2 ILE A 982 ASN A 986 0 SHEET 2 AA7 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983 SHEET 1 AA8 2 TYR A1008 LYS A1009 0 SHEET 2 AA8 2 LYS A1030 PHE A1031 -1 O PHE A1031 N TYR A1008 LINK C GLU B1006 N PTR B1007 1555 1555 1.33 LINK C PTR B1007 N TYR B1008 1555 1555 1.33 LINK C GLU A1006 N PTR A1007 1555 1555 1.33 LINK C PTR A1007 N TYR A1008 1555 1555 1.32 CISPEP 1 ALA A 920 GLY A 921 0 -11.00 SITE 1 AC1 13 GLU A 987 ALA B 880 VAL B 911 MET B 929 SITE 2 AC1 13 GLU B 930 TYR B 931 LEU B 932 GLY B 935 SITE 3 AC1 13 ARG B 980 ASN B 981 LEU B 983 GLY B 993 SITE 4 AC1 13 ASP B 994 SITE 1 AC2 13 LEU A 855 ALA A 880 VAL A 911 MET A 929 SITE 2 AC2 13 GLU A 930 LEU A 932 GLY A 935 ARG A 980 SITE 3 AC2 13 ASN A 981 LEU A 983 GLY A 993 ASP A 994 SITE 4 AC2 13 HOH A1413 CRYST1 112.131 112.131 70.577 90.00 90.00 90.00 P 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008918 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008918 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014169 0.00000